Ubs Group Ag Quidel Ortho Corp Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Quidel Ortho Corp stock. As of the latest transaction made, Ubs Group Ag holds 64,307 shares of QDEL stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,307

Previous 39,862 61.32%

Holding current value

$2.41 Million

Previous $1.32 Million 121.37%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$29.96 - $46.4 $732,372 - $1.13 Million	24,445 Added 61.32%	64,307 $2.93 Million
Q2 2024 Aug 13, 2024	BUY	$32.9 - $47.0 $287,973 - $411,391	8,753 Added 28.14%	39,862 $1.32 Million
Q1 2024 May 13, 2024	SELL	$41.76 - $74.73 $711,005 - $1.27 Million	-17,026 Reduced 35.37%	31,109 $1.49 Million
Q4 2023 Feb 09, 2024	BUY	$58.16 - $75.44 $2.62 Million - $3.39 Million	44,990 Added 1430.52%	48,135 $3.55 Million
Q3 2023 Nov 09, 2023	SELL	$70.9 - $88.63 $101,316 - $126,652	-1,429 Reduced 31.24%	3,145 $229,000
Q2 2023 Aug 11, 2023	SELL	$81.09 - $94.16 $1.5 Million - $1.74 Million	-18,478 Reduced 80.16%	4,574 $379,000
Q1 2023 May 12, 2023	SELL	$82.98 - $91.46 $2.93 Million - $3.23 Million	-35,264 Reduced 60.47%	23,052 $2.05 Million
Q4 2022 Feb 08, 2023	BUY	$66.93 - $97.5 $2.75 Million - $4.01 Million	41,139 Added 239.5%	58,316 $5 Million
Q3 2022 Nov 10, 2022	SELL	$69.86 - $107.63 $3.7 Million - $5.7 Million	-52,976 Reduced 75.51%	17,177 $1.23 Million
Q2 2022 Aug 10, 2022	BUY	$89.06 - $117.64 $6.25 Million - $8.25 Million	70,153 New	70,153 $6.82 Million

Others Institutions Holding QDEL

# of Institutions

293

Shares Held

67.9M

Call Options Held

337K

Put Options Held

134K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.51B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account